Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Singapore’s NTU launches nationwide research initiative to promote lung health

Singapore’s NTU launches nationwide research initiative to promote lung health

this week, ​​ Nanyang Technological University (NTU) in Singapore announced
the launch of a nationwide research initiative on lung health.

formation of the Academic Respiratory
Initiative for Pulmonary Health (TARIPH) was officially announced at
the 2nd International
Symposium on Respiratory Research, hosted by NTU's Lee Kong Chian School
of Medicine (LKCMedicine) at its Novena campus.

nationwide research initiative aims to understand the unique characteristics of
lung diseases in Singapore and improve their prevention, treatment and care

the high burden of lung diseases in Singapore, LKCMedicine is taking the lead
in driving respiratory research to deepen our understanding of lung health,
improve prevention and develop better treatments for lung diseases, with a
focus on the population of Singapore and its region," said Professor James
Best, Dean of the LKCMedicine.

disease is a major contributor to disease burden in Singapore, with Chronic
Obstructive Pulmonary Disease (COPD) rising in terms of leading causes of
death, while asthma has moderate prevalence but high rates of mortality.

the rapidly ageing population and contributing factors such as environmental
pollution, prevalence of respiratory disease could worsen and through research,
TARIPH will be best placed to address the challenge ahead.

diseases affect different ethnicities in different ways. However, existing
research and treatment recommendations for lung diseases focus on data from
Caucasian populations.

TARIPH, spearheaded by NTU's
LKCMedicine, aims to address this pressing gap in knowledge for the Singaporean
population and Asian patients.

will focus on the full spectrum of research – from bench to bedside and to the
population. Its flagship research effort will characterise lung diseases at the
molecular level to understand the cause of illness in Asian patients. At the
same time, clinical data from hospitals and clinics in Singapore will allow
clinician scientists to address pertinent questions that will improve clinical
care in the near future,” Professor Best added.

findings from TARIPH could aid policymakers and the healthcare sector in
determining strategies and implementation of medical interventions, healthcare
delivery and access, health promotion and disease awareness in Singapore, and
potentially throughout Asia.

Credit: NTU

a start, TARIPH will bring together more than 30 investigators from local and
international institutions to generate evidence on how lung diseases present
and develop in local patient populations.

TARIPH investigators are from Singapore's research agencies, hospitals and
polyclinics, and international partners such as the University of Newcastle,
Australia, Imperial College London, University of British Columbia, Canada, and
the Karolinska Institutet, Sweden. They have diverse backgrounds ranging
from physiology, engineering to data analytics, epidemiology and clinical

The Phenotypes of Respiratory Disease

to start this year, TARIPH's
flagship project "Phenotypes of Respiratory Disease" will
detail the characteristics, behaviours and progression of respiratory diseases
specific to Singapore.

will allow medical decisions, practices and interventions to be tailored to
Asians and the individual rather than the disease. It will develop new DNA-based
tests for common lung infections.

will also study the economic and social costs of respiratory disease in
Singapore and examine how to improve the ways chronic lung disease patients
access care.

will be other collaborative and interdisciplinary projects under TARIPH, some
of which are already underway. They include:

Fungal Profiling of Bronchiectasis

study is led by investigators from LKCMedicine and involves TARIPH members from
Tan Tock Seng Hospital, Singapore General Hospital, Changi General Hospital and
A*STAR institutes, the Institute of Molecular & Cell Biology and the Genome
Institute of Singapore. 

study found that the rate of fungal infections underlying bronchiectasis, a
disease in which there is permanent enlargement of parts of the airways of the
lung, is remarkably high in Asian populations.

addition to setting out localised guidelines that take these factors into
consideration, the team is also looking into developing new rapid diagnostics
to identify patients early, so that further damage to already-damaged lungs can
be prevented.

Barriers to accessing care in the

patients with chronic lung diseases, such as asthma and chronic obstructive
pulmonary disease (COPD), seek help very late, when they are already unwell and
need urgent treatment. 

team of TARIPH collaborators at LKCMedicine and in the polyclinics will study
the factors that prevent patients here from seeking help early, and identifying
potential touchpoints for meaningful interventions, which will be evaluated
through nation-wide clinical trials.

Understanding early Inflammatory,
infectious and immune changes in COPD

project examines molecular mechanisms of early COPD using a novel cohort of
Singaporean smokers at risk of lung function decline and thus COPD. 

The participants are recruited through
collaboration with local TARIPH clinicians, primary care leaders and NTU's
newly established Centre for Population Health Sciences (CePHas). It aims to
identify early signs of COPD to develop new biomarkers and new targets for
therapeutic intervention.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.